UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer
Crossref DOI link: https://doi.org/10.1007/s10147-015-0937-x
Published Online: 2015-12-28
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miyata, Yoshinori http://orcid.org/0000-0003-1155-1038
Touyama, Tetsuo
Kusumi, Takaya
Morita, Yoshitaka
Mizunuma, Nobuyuki
Taniguchi, Fumihiro
Manabe, Mitsuaki
License valid from 2015-12-28